Johnson & Johnson, FDA, CDC
CDC and FDA recommend halt on J&J vaccine. J&J stock prices fell by 1.34%.
▪ The CDC and FDA released an advisory on Tuesday to halt the use of the Johnson & Johnson one-shot COVID-19 vaccine.
▪ The federal bodies decided to investigate the vaccine after receiving six reports of a rare and fatal blood clotting disease, ‘cerebral venous sinus thrombosis’ (CVST), in women between the ages of 18 to 48.
▪ Dr. Anthony Fauci, Biden’s chief medical adviser, said almost 7 million people took the J&J shot, and officials reported CVST in less than one in a million cases.
▪ White House COVID-19 Response Coordinator Jeff Zients assured that the US has a sufficient supply of the Pfizer and Moderna vaccines, and the J&J vaccine halt will not affect the US vaccination drive.
Direct, authoritative source material on this story.
Articles Citable has ingested related to this story.
Percentage of day’s news
Citable analysis assessing the language of each article related to the story as positive, negative or neutral.
Publications covering this story along with their cumulative positive or negative sentiment.